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THE most convincing demonstrations of antigenic differences between tumour
cells and those of the animal bearing the tumour have involved transplantation
techniques. There seems little doubt that tumour-bearing animals may under
some circumstances produce an immune response against tumour-specific antigens.
Theliterature on antigenic differences between normalandtumour cells is extensive
and is well reviewed by Haddow (1965). Although relatively less work has been
carried out on the immunology ofhuman tumours, the evidence so far obtained is
generally compatible with the findings in experimental animals and indicates the
existence ofhuman tumour specific antigens (Graham and Graham, 1955; Makari,
1955; Burrows, 1958; De Carvalho, 1960; Finney, Byers and Wilson, 1960;
Nairn, Richmond, McEntegart and Fothergill, 1960; Buttle, Eperon and Kovacs,
1962; Goudie and McCallum, 1962; McKenna, Sanderson and Blakemore, 1962;
Nairn, Fothergill, McEntegart and Richmond, 1962; De Carvalho, Rand and
Ashby, 1963; Greenspan, Brown and Schwarts, 1963). Transplantation studies
are not normally practicable in man, and investigators have used a variety of
other techniques. If human tumours possess antigens distinct from those of the
tissues of the individual concerned, tumour-specific autoantibody responses
should sometimes be detectable and yet reports of such responses are scanty
(Graham and Graham, 1955; Finney, Byers and Wilson, 1960). The following
investigation employs a wide range of serological techniques and tumour antigen
preparations in an attempt to investigate the frequency of circulating auto-
antibodies to human tumour antigens.
MATERIALS AND METHODS
Preparation of antigens and sera
Tumour tissue and corresponding normal tissue was taken from fresh surgical
specimens. Small blocks of both normal and tumour tissue were quick frozen for
subsequent sectioning, and the remainder, dissected free of attached fat, fibrous
tissue, etc., was divided into three portions after washing as free of blood as
possible with chilled saline. The three aliquots of tissue were finely sliced,
weighed, and then were homogenised at a temperature of between 0 and 50 C.
in one of the following: distilled water, isotonic phosphate buffered saline pH 7-2,
or isotonic sucrose, in the proportion of 1 g. tissue to 10 ml. solution.
The homogenates in sucrose solution were fractionated by differential centri-
fugation as described by Schneider (1948) for the separation of microsomes and
mitochondria. The microsomal and mitochondrial fractions and the sucrose
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supernatant were used as separate antigen preparations. The homogenates in
water and in saline were lightly centrifuged to eliminate large particles and were
also used as separate antigen preparations. All antigen preparations were stored
at -20° C. until required.
Venous blood was taken from patients undergoing surgery for carcinoma 48 to
72 hours after operation. Serum samples were stored at -20° C. until required.
Where necessary sera were inactivated by heat at 56° C. for 30 minutes and were
then exhaustively absorbed with packed sheep erythrocytes, both at 370 and 40 C.
The following tumours and corresponding normal tissues were examined:
Carcinoma oesophagus 2
Carcinoma bronchus 5
Carcinoma breast 6
Carcinoma stomach 3
Carcinoma colon 8
Carcinoma rectum 10
Total cases 34
Testsfor antibody
(a) Double diffusion in gel.
The water, saline and sucrose soluble extracts of normal and tumour tissues
were diffused against patient's own serum in 0.8% agar using a variety of punch
patterns. They were inspected at intervals for the development ofprecipitin lines.
(b) Tanned cell agglutination technique (Boyden, 1951).
Several dilutions of saline and sucrose soluble fractions of normal and tumour
tissues were incubated in equal volumes with a 2% suspension of tannic acid
treated sheep erythrocytes at room temperature for 45 minutes. Equal volumes
(0.2 ml.) of washed antigen-treated cells and serum dilutions were incubated in
haemagglutination trays and the resulting red cell pattern examined. Controls
to detect non-specific agglutination were set up.
(c) Bisdiazotised benzidine technique (Stavitsky and Arquilla, 1955).
Several dilutions of saline and sucrose soluble fractions of normal and tumour
tissues were incubated with several concentrations of bisdiazotised benzidine and
sheep erythrocytes at room temperature for 10 minutes. The cells were washed
and used in tests to detect antibody as in the tanned cell agglutination technique.
(d) Red cell surface absorption technique (modified from Middlebrook and
Dubos, 1948).
Dilutions of saline and sucrose soluble fractions of normal and tumour tissues
were incubated with washed packed sheep erythrocytes in the proportion to give
a final concentration of 5% cells. After incubation for 2 hours at 370 C. the
antigen treated cells were washed and made up to 0-5% suspension. Equal
volumes of cells and serum dilutions were mixed and examined for haemagglutina-
tion after 2 hours' incubation at 370 C.
(e) Complement fixation (micro method of Fulton and Dumbell, 1949).
Several dilutions of microsomal and mitochondrial preparations from normal
and tumour tissues were tested against complement-deactivated dilutions of
patients' serum. A normal human serum was used as negative control. Fixation
was carried out for 18 hours at 40 C. End points were read at 50% haemolysis.
(f) Complement fixation (semi-micro method modified from Donnelly, 1959).
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Dilutions of water, saline and sucrose soluble fractions of normal and tumour
tissues were tested against dilutions of patients' serum. 2 M.H.D. of guinea-pig
complement was used and fixation was carried out at 370 C. for 1 hour. Appro-
priate controls were used and the results were read to a 50% haemolysis end point.
(g) Fluorescent antibody technique (Cherry, Goldman, Carski, and Moody,
1960).
Unfixed 5#a frozen sections of normal and tumour tissues were incubated with
test and with control normal human serum for 30 minutes at 370 C. After
thorough washing they were then incubated with a fluorescein isothiocyanate
conjugated goat anti-human GammaG serum for a further 30 minutes at 370 C.
Sections were washed, mounted in neutral glycerol and examined for fluorescence
in u.v. light.
RESULTS
In the majority of the 34 cases examined, all antibody detection tests were
negative. In 3 sera antibody was detected. One serum from a patient with a
carcinoma of rectum had complement-fixing antibody against tumour mito-
chondria which failed completely to react with the mitochondrial preparation
from normal rectal mucosa from the same patient. Optimum fixation occurred
with serum diluted 1/5 and antigen 1/10 when 41 units of C' were bound. Anti-
body reacting in a similar manner, i.e. against the tumour mitochondrial prepara-
tion only, was found in serum from a case of carcinoma of colon. In this case
3*25 units ofcomplement were fixed using 1/5 serum and 1/100 antigen; no fixation
at all occurred with mitochondrial preparation from normal tissue. It should
be noted that both complement fixing antigens proved to be very labile and short
periods at room temperature resulted in some loss of activity. Neither serum
giving positive complement fixation produced convincing positive immuno-
fluorescence. In serum from a second patient with carcinoma of rectum, specific
fluorescent staining of the cytoplasm of tumour cells was demonstrated by the
fluorescent antibody technique. The serum also produced specific fluorescence
ofthe cytoplasm of mucus-secreting cells in sections ofnormal rectal mucosa, but
whereas in this case good fluorescence was observed when the serum was diluted
1/8, the tumour cells fluoresced poorly when the serum was diluted 1/4. This
suggests that the tumour cells probably contain less antigen than normal colonic
epithelial cells.
DISCUSSION
In only 3 ofthe 34 cases examined was an autoimmune response demonstrated.
In 2 of these the antigen appears to be tumour specific and in the third to be
present both in tumour cells and in the corresponding normal cells. An unusual
feature of the 2 instances of tumour specific antigens is their apparent mito-
chondrial nature. Other evidence suggests that human tumour antigens are
soluble, although their molecular type is not clear having been suggested to be
protein (De Carvalho, 1960; De Carvalho, Rand and Ashby, 1963; McKenna,
Sanderson and Blakemore, 1962), polypeptide (Graham and Graham, 1955;
Burrows and Neil, 1958), or polysaccharide (Makari, 1958). Neither does the
autoantibody detected here appear to be identical with that described by von
Kleist and Burtin (1966) which reacts with an antigen present in both normal and
neoplastic colonic epithelium which may be microsomal in nature.
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The antigen demonstrated by fluorescent antibody in the case of carcinoma
rectum may be of a similar type to that demonstrated by Nairn, Fothergill,
McEntegart and Richmond (1962) in normal colonic mucosa, but lacking in
neoplastic tissue; in the present case the tumour tissue still retaining some of the
antigen.
The results show that some human tumours undoubtedly have new antigen,
and that an autoimmune response to these antigens may sometimes occur. The
low frequency of detection of an autoimmune response requires explanation.
Several possibilities arise. " New " tumour antigen may be uncommon, although
this seems unlikely particularly in view of their demonstration in experimental
animal tumours. They may not be released from the tumour and so not encounter
an immunologically competent cell. This also is unlikely in view ofthe frequency
of some degree of necrosis in most malignant tumours. The serum samples used
in this investigation were collected within 2-3 days of surgery. It is possible
that whilst the tumour is in situ, a slow constant release of tumour antigen
combines with any antibody produced and so the latter is not detectable in serum.
This possibility is currently being investigated.
SUMMARY
Using a wide variety of serological techniques autoantibodies reacting with
tumour specific antigens were sought in 34 cases of human carcinoma. Auto-
antibodies were found in 2 cases of intestinal carcinoma (rectum and colon).
These reacted against tumour mitochondrial preparations but not against normal
colonic epithelial cell mitochondrial preparations from the same individual.
Non-tumour specific autoantibodies were also found in one case of carcinoma
rectum.
We wish to thank the Research Grants Committee of the United Manchester
Hospitals for supporting this project.
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